NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 116

Registration Number: NCT00000656

Locations: 🇺🇸
Univ of Washington, Seattle, Washington, United States
🇺🇸
Palo Alto Veterans Adm Med Ctr / Stanford Univ, Palo Alto, California, United States
🇺🇸
Whitman - Walker Clinic, Washington, District of Columbia, United States

and more 2 locations

Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine

Not Applicable

Completed

Conditions: Herpes Simplex
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 25

Registration Number: NCT00000635

Locations: 🇺🇸
University of Colorado Hospital CRS, Aurora, Colorado, United States
🇺🇸
NY Univ. HIV/AIDS CRS, New York, New York, United States
🇺🇸
Cook County Hosp. CORE Ctr., Chicago, Illinois, United States

and more 5 locations

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

Phase 3

Completed

Conditions: HIV Infections
Lipodystrophy

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 630

Registration Number: NCT00006412

Locations: 🇺🇸
Philadelphia Veterans Administration Med Ctr, Philadelphia, Pennsylvania, United States
🇺🇸
Univ of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Case Western Reserve Univ, Cleveland, Ohio, United States

and more 55 locations

A Study to Compare Two Different Anti-HIV Drug Regimens

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 120

Registration Number: NCT00000924

Locations: 🇺🇸
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States
🇺🇸
Cook County Hosp, Chicago, Illinois, United States
🇺🇸
Chicago Children's Memorial Hosp, Chicago, Illinois, United States

and more 42 locations

The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 18

Registration Number: NCT00000898

Locations: 🇺🇸
Univ of California/ San Francisco / Dept of Medicine, San Francisco, California, United States
🇺🇸
Stanford Univ Med Ctr, Stanford, California, United States
🇺🇸
San Francisco Gen Hosp, San Francisco, California, United States

and more 1 locations

A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Phase 1

Completed

Conditions: HIV Infections
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT00000887

Locations: 🇺🇸
Usc La Nichd Crs, Los Angeles, California, United States
🇺🇸
UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases, Chapel Hill, North Carolina, United States
🇺🇸
Tulane Univ. Health Science Ctr., Tulane Univ. Hosp. & Clinic, New Orleans, Louisiana, United States

and more 4 locations

A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-28

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 210

Registration Number: NCT00000791

Locations: 🇺🇸
Washington U CRS, Saint Louis, Missouri, United States
🇺🇸
Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸
Weiss Memorial Hosp., Chicago, Illinois, United States

and more 19 locations

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

Not Applicable

Completed

Conditions: Herpes Simplex
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2016-10-31

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 75

Registration Number: NCT00001115

Locations: 🇺🇸
Univ of Illinois Chicago / Howard Brown Hlth Ctr, Chicago, Illinois, United States
🇺🇸
Univ of Illinois - Chicago, Chicago, Illinois, United States
🇺🇸
Johns Hopkins Univ, Baltimore, Maryland, United States

and more 12 locations

Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT00006443

Locations: 🇺🇸
Michael S. Saag, Birmingham, Alabama, United States

A Study of the Effects of Advantage 24 on the Rectum

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 70

Registration Number: NCT00000929

Locations: 🇺🇸
Univ of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy